Spectrum of cutaneous lesions in a cohort of patients with neurofibromatosis type 2.

Cutaneous lesions are frequent in NF2 and may precede the diagnosis by several years. Their identification is important to establish the diagnosis earlier and potentially reduce morbidity and mortality.